GALMED PHARMACEUTICALS LTD. Cash and Restricted Cash
GALMED PHARMACEUTICALS LTD. (GLMD) had Cash and Restricted Cash of $7.06 million as of 2020-12-31, per its 20-F filed 2021-03-18.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2021-03-18
- 2020-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.06M.
- 2020-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.67M.
- 2019-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $16.04M.
- 2019-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $25.78M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2020-12-31 | $7.06M 20-F · filed 2021-03-18 |
| 2020-06-30 | $5.67M 6-K · filed 2020-08-06 |
| 2019-12-31 | $16.04M 20-F · filed 2021-03-18 |
| 2019-06-30 | $25.78M 6-K · filed 2020-08-06 |
| 2018-12-31 | $24.16M 20-F · filed 2021-03-18 |
| 2017-12-31 | $13.02M 20-F · filed 2021-03-18 |
| 2016-12-31 | $3.10M 20-F · filed 2020-03-12 |